Annual report pursuant to Section 13 and 15(d)

Revenue, Contract Assets and Liabilities and Other Contract Matters - Schedules of Concentration of Risk, by Risk Factor (Details)

v3.19.3.a.u2
Revenue, Contract Assets and Liabilities and Other Contract Matters - Schedules of Concentration of Risk, by Risk Factor (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue $ 79,445 $ 75,802 $ 80,456 $ 67,605 $ 60,231 $ 49,712 $ 54,014 $ 57,290 $ 303,308 $ 221,247 $ 171,022
Sales Revenue, Net | Customer Concentration Risk | Customer A                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                 52,310    
Sales Revenue, Net | Customer Concentration Risk | Customer B                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                 39,897    
Sales Revenue, Net | Customer Concentration Risk | Customer C                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                 36,175 49,123 21,781
Sales Revenue, Net | Customer Concentration Risk | Customer D                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                 $ 34,448    
Sales Revenue, Net | Customer Concentration Risk | Customer E                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                   25,873  
Sales Revenue, Net | Customer Concentration Risk | Customer F                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                   $ 23,279  
Sales Revenue, Net | Customer Concentration Risk | Customer G                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Revenue                     $ 44,724